Hyderabad: Biofabri, a global human vaccine development company and part of the Zendal Group, and Bharat Biotech International Limited (BBIL) have signed a Technology Transfer Agreement aimed at advancing global access to MTBVAC, a next-generation tuberculosis (TB) vaccine candidate.The agreement...